Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crane (CR) Gains from Investment Securities (2022 - 2025)

Crane (CR) has disclosed Gains from Investment Securities for 4 consecutive years, with -$56.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities fell 413.26% to -$56.7 million in Q3 2025 year-over-year; TTM through Dec 2025 was -$500000.0, a 91.8% increase, with the full-year FY2025 number at -$500000.0, up 91.8% from a year prior.
  • Gains from Investment Securities was -$56.7 million for Q3 2025 at Crane, down from $56.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $79.1 million in Q3 2023 to a low of -$84.8 million in Q4 2024.
  • A 4-year average of -$1.8 million and a median of $19.0 million in 2024 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: soared 221.92% in 2024, then tumbled 413.26% in 2025.
  • Crane's Gains from Investment Securities stood at $61.0 million in 2022, then plummeted by 231.31% to -$80.1 million in 2023, then dropped by 5.87% to -$84.8 million in 2024, then soared by 33.14% to -$56.7 million in 2025.
  • Per Business Quant, the three most recent readings for CR's Gains from Investment Securities are -$56.7 million (Q3 2025), $56.2 million (Q2 2025), and -$84.8 million (Q4 2024).